Transhemangioma Ablation of Hepatocellular Carcinoma

Journal Article · Sat Dec 15 00:00:00 EST 2012 · Cardiovascular and Interventional Radiology

DOI:https://doi.org/10.1007/S00270-012-0430-0· OSTI ID:22066488

Pua, Uei ^[1]

---

1. Tan Tock Seng Hospital, Department of Diagnostic Radiology (Singapore)

Radiofrequency ablation (RFA) is a well-established treatment modality in the treatment of early hepatocellular carcinoma (HCC) [1]. Safe trajectory of the RFA probe is crucial in decreasing collateral tissue damage and unwarranted probe transgression. As a percutaneous technique, however, the trajectory of the needle is sometimes constrained by the available imaging plane. The presence of a hemangioma beside an HCC is uncommon but poses the question of safety related to probe transgression. We hereby describe a case of transhemangioma ablation of a dome HCC.

• OSTI ID: 22066488
• Journal Information: Cardiovascular and Interventional Radiology, Vol. 35, Issue 6; Other Information: Copyright (c) 2012 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Article Copyright (c) 2012 Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Country of input: International Atomic Energy Agency (IAEA); ISSN 0174-1551
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
ABLATION
ANGIOMAS
DAMAGE
HEPATOMAS
RADIOLOGY
RADIOWAVE RADIATION
SAFETY